Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic - PRO-SERO-COV

NCT04426006 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT04426006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04426006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic - PRO-SERO-COV
Lead sponsor
Institut Bergonié
Phase
Not applicable
Overall status
Completed
Start date
June 18, 2020
Completion date
October 4, 2021
Enrollment
526 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov2, serum; disease